Nanostructured solid acid catalysts for sustainable chemical manufacturing. This project aims to develop next-generation solid acid catalysts for energy- and atom-efficient transformations of waste biomass and carbon dioxide to sustainable chemicals and fuels. Catalysis is a transformative technology, key to both life and lifestyle, contributing to 90% of chemical manufacturing processes and >20% of all industrial products, and will be a key enabler for the emerging Australian bioeconomy. The ex ....Nanostructured solid acid catalysts for sustainable chemical manufacturing. This project aims to develop next-generation solid acid catalysts for energy- and atom-efficient transformations of waste biomass and carbon dioxide to sustainable chemicals and fuels. Catalysis is a transformative technology, key to both life and lifestyle, contributing to 90% of chemical manufacturing processes and >20% of all industrial products, and will be a key enabler for the emerging Australian bioeconomy. The expected development of new high performance catalysts for the production of renewable transportation fuels and sustainable chemical feedstocks will underpin commercially viable low carbon technologies using waste resources, and should provide significant benefits to Australian science, industry, and the environment.
Read moreRead less
ARC Centre of Excellence for Green Electrochemical Transformation of Carbon Dioxide. ARC Centre of Excellence for Green Electrochemical Transformation of Carbon Dioxide. This Centre aims to advance carbon dioxide electrochemistry innovations to enable the conversion of carbon dioxide into valuable products and transition Australia to a carbon-neutral economy. This Centre expects to generate new knowledge using experimental and computational approaches to develop systems-level understanding to fu ....ARC Centre of Excellence for Green Electrochemical Transformation of Carbon Dioxide. ARC Centre of Excellence for Green Electrochemical Transformation of Carbon Dioxide. This Centre aims to advance carbon dioxide electrochemistry innovations to enable the conversion of carbon dioxide into valuable products and transition Australia to a carbon-neutral economy. This Centre expects to generate new knowledge using experimental and computational approaches to develop systems-level understanding to furnish industry-ready carbon dioxide utilisation technologies. Expected outcomes include enhanced capacity through collaborations establishing the Centre as an international hub for research, training, technology translation and strategic advice for stakeholders and policymakers. This should accelerate Australia’s progress towards net zero emissions targets and grow a sustainable economy and create future jobs.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE120100112
Funder
Australian Research Council
Funding Amount
$275,000.00
Summary
A Raman facility for advanced research supporting Australia’s natural gas, oil, coal and minerals industries. This modern Raman Spectroscopy facility will support the science and engineering that underpins the production and processing of Australia’s natural resources. Using high-pressure fibre optics, novel lasers and advanced imaging, the facility will enable the monitoring and improvement of processes and materials under extreme conditions.
Novel Insights Into The Pathobiology Of Alphavirus Infections
Funder
National Health and Medical Research Council
Funding Amount
$827,660.00
Summary
Infections with mosquito-borne viruses are increasing at an alarming rate worldwide. Ross River virus is endemic in parts of Australia, PNG and Pacific islands, while chikungunya virus is distributed globally and causes recurrent pandemics that involve millions of people. These viruses cause severe musculoskeletal disease for several months after infection. This project aims to establish how these viruses interact with the human host to cause disease and may provide a basis for new treatments.
A National Population-based Study Of Rheumatic Heart Disease In Pregnancy
Funder
National Health and Medical Research Council
Funding Amount
$877,826.00
Summary
Whilst overall a rare disease, Indigenous peoples have disproportionately high rates of rheumatic heart disease (RHD). This study explores the prevalence and distribution of RHD in pregnancy in Australia and New Zealand. It details current management, diagnostic and referral process and risk factors. Key attributes of culturally safe models of care for RHD in pregnancy are explored, particularly as they relate to Indigenous women. Findings will inform policy, guidelines and education resources.
Arbovirus Activation And Modulation Of NLRP3 Inflammasome
Funder
National Health and Medical Research Council
Funding Amount
$779,720.00
Summary
This project aims to establish how mosquito borne viruses such as Ross River and dengue viruses interacts with the human host to cause disease, including how the virus evades the host’s immune response to persist and cause disease for prolonged periods. Knowing how differences in the virus and the host’s immune system interplay to cause asymptomatic to severely disabling disease will assist in devising new treatments and prevention programs to lessen the impact of these diseases in Australia.
Mosquito-borne alphaviruses such as Ross River and chikungunya viruses cause widespread epidemics and exert extreme pressure on the public health systems of affected regions. Alphaviruses spreads to joints and triggers a severe disease in those affected. There are no effective treatments or vaccines. The project will investigate virus-host interaction at the bite site. The outcome will be new knowledge to treat infection at the mosquito bite site to prevent joint disease.
Glycotherapeutics; A New Class Of Treatment For Alphavirus-induced Musculoskeletal Disease
Funder
National Health and Medical Research Council
Funding Amount
$449,868.00
Summary
The hallmark of alphavirus disease is crippling pain and joint arthritis, which often has an extended duration. Currently there is no licenced specific treatment for alphavirus disease and the increasing spread of infection highlights an urgent need for therapeutic intervention strategies. This grant looks at the potential of pentosan polysulfate as a promising drug-repurposing candidate for the treatment of alphavirus-induced arthritis.